A systematic study of the oxidative folding of murine prion protein mPrP(23±231) is reported here. Folding of mPrP(23±231) involves formation of a single disulfide bond, Cys179±Cys214. Despite this simplicity, reduced mPrP(23±231) exhibits numerous unusual folding properties. In the absence of denaturant, folding of mPrP(23±231) is extremely sluggish, regardless of pH. The optimal pH for mPrP(23±231) folding was found to be 4±5. At pH 8.0, a condition that typically favors disulfide formation, folding of mPrP(23±231) hardly occurs, and it not facilitated by inclusion of redox agent. In the presence of denaturant (4 m urea or 2 m guanidine hydrochloride) and basic pH (8.0), reduced mPrP(23±231) refolds to the native structure quantitatively. The efficiency of folding can be further promoted by the presence of oxidized glutathione. At pH 4.0 and in the presence of 4 m urea, reduced mPrP(23±231) converts to three distinctive conformational isomers, unable to form the native structure. These unusual properties lead us to the following conclusions. The reduced mPrP(23±231) adopts a highly rigid structure with the two cysteines buried or situated apart. The presence of denaturant or low pH disrupts this rigid structure and lowers the energy barrier, which permits oxidation and refolding of the reduced mPrP(23±231). Under selected conditions, reduced mPrP(23±231) is capable of taking on multiple forms of stable conformational isomer that are segregated by energy barriers.
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Prion diseases are neurodegenerative diseases that afflict both humans and animals. They include the well-known mad cow diseases, scrapie in sheep, and Creutzfeldt-Jakob disease, familial insomnia and kuru in humans [1±5] . They have been demonstrated to be`protein only' diseases [1, 3, 6] . The underlying cause of prion disease is the conversion of a host-derived cellular prion protein (PrP . Both PrP C and PrP SC have the same molecular mass and amino-acid sequences [7] . They differ only by their conformation and this conformational difference is associated with a considerable dissimilarity in their physicochemical properties. Unlike PrP C , which is soluble, susceptible to enzyme digestion and rich in a-helical structure, PrP SC is highly insoluble, resistant to proteolytic digestion and possesses a high b sheet content [2, 3, 8, 9] .
To date, the majority of structural data were gained from and focused on PrP C . The NMR structures of various lengths of mouse PrP C are known [10±14]. They contain three well-resolved helices and a short two-stranded b sheet. On the other hand, structural analysis of PrP SC has been hampered by its poor solubility. Numerous efforts have also been made to search for conditions that would generate prion isomers with an increased content of b sheet structure. PrP C contains one disulfide-bond, is structurally plastic and may exist in various conformations under different conditions [15] . The b sheet structure can be formed with or without disruption of the disulfide bond. At elevated temperatures, PrP C converts irreversibly to a stable b sheet form [15] . A scrapie-like prion rich in b sheet was found to be an unfolding intermediate at pH 4.0 in the presence of 3.5 m of urea [16] . A similar stable unfolding intermediate was observed at pH 3.6±4.0 under 1±2 m guanidine hydrochloride (GdmCl) [9, 17] . Reduction of the disulfide bond in the presence of dithiothreitol (100 mm) and 6 m GdmCl also converts PrP C to a similar structure with high b sheet content [8, 18] . However, it is relevant to keep in mind that while PrP SC may possess a high content of b sheet structure, individual folding and unfolding intermediates with packed b sheet structures do not necessarily represent PrP SC . Preparation and isolation of murine PrP C from inclusion bodies require an oxidation step to form the disulfide bond between Cys179 and Cys214. This is routinely achieved by incubating the sample in alkaline pH in the presence of 8 m urea [19] . A thorough analysis of the oxidation of reduced Syrian hamster recombinant PrP has also been reported [15] . Despite these efforts, the interdependent effect of pH, redox agent and denaturant on the oxidative folding of reduced prion remains to be demonstrated. These data are crucial for revealing the conformational flexibility and folding mechanism of the prion molecule. In this study we have conducted a systematic analysis of the oxidative folding of murine prion mPrP(23±231). Specifically, we have evaluated the individual and combined effects of pH, redox agent and denaturant on the folding behavior of mPrP(23±231). Our aims are to understand further the conformational stability and plasticity of the prion molecule and to detect stable conformational isomers that may be present during the folding of reduced mPrP(23±231).
E X P E R I M E N T A L P R O C E D U R E S

Materials
The plasmid pRBI-PDI-T7 for expression of mPrP(23±231) was kindly supplied by R. Glockshuber (ETH, Zurich, Switzerland). Tryptone and yeast extract were from Fisher Scientific. Isopropyl thio-b-d-galactoside, 1,4-dithio-dlthreitol, phenylmethanesulfonyl fluoride, pepsin and a-chymotrypsin were purchased from Sigma. Tris(2-carboxyethyl) phosphine was obtained from Pierce. Proteinase K was from Boehringer Mannheim GmbH (Germany). The Amicon ultrafiltration unit and YM10 membranes were from Millipore. Sephadex Fast-Flow and NAP-5 columns were from Pharmacia. All other chemicals were of analytical grade. Protein samples for the refolding study were further purified by RP-HPLC.
Expression and purification of recombinant mPrP(23±231)
This was achieved using the method developed by Hornemann et al. [19] . Protein concentrations were measured by the Bradford method (Bio-Rad). The purified protein was verified by Edman sequencing, SDS/PAGE, CD and MALDI-TOF MS. MALDI-TOF mass analysis was performed with a Voyager-DE TM STR from PerSeptive Biosystems. The calibration was performed either externally or internally, using two standard proteins (myoglobin, M r 16 952 and carbonic anhydrase, M r 29 022).
Oxidative folding of mPrP(23±231) in the absence of denaturant and redox agent
The native protein was first reduced and denatured by incubation in Tris/HCl buffer (0.1 m, pH 8.0) containing 100 mm of dithiothreitol and GdmCl (6 m) at 23 8C for 90 min. The reducing reagent and denaturant were removed by passing the solution through a NAP-5 column (Pharmacia, G-25) equilibrated in 20 mm sodium acetate buffer (pH 5.0). Samples were then made ready for folding experiments by concentration to a protein concentration of 0.5 mg´mL 21 using Ultrafree centrifugal filters (Millipore, Biomax, 5K). To initiate folding, freshly prepared reduced/ denatured protein was diluted to 0.1 mg´mL 21 in buffers of selected pH. Folding reactions were performed at 23 8C and trapped in a time-course manner by mixing aliquots of the sample with an equal volume of 4% trifluoroacetic acid in water. Acid-trapped samples were analyzed by HPLC using the following conditions. Solvent A was water containing 0.088% trifluoroacetic acid. Solvent B was 90% acetonitrile in water (by volume) containing 0.084% trifluoroacetic acid. The gradient was 28±48% solvent B in 25 min. The column was Zorbax 300 SB-C18 4.6 mm Â 25 cm.
The flow rate was 0.5 mL´min 21 . The temperature of the column was 23 8C.
Oxidative folding of mPrP(23±231) in the presence of redox reagent and/or denaturant
Folding experiments were carried out in the Tris/HCl buffer (0.1 m, pH 8.0) or sodium acetate buffer (10 mm, pH 4.0). Folding reactions were prepared as described above. However, selected concentrations of redox reagent and/or denaturant (4 m urea or 2 m GdmCl) were introduced during the step of dilution of the concentrated sample shortly before the folding reaction was initiated.
Identification of mPrP(23±231) folding intermediates
Protein purified by HPLC was freeze-dried and modified with 4-vinylpyridine in the Tris/HCl buffer (pH 8.0) for 30 min at 23 8C. Modified samples were desalted by a NAP-5 column using 0.5% trifluoroacetic acid or by HPLC using the same conditions as stated above. All of the samples were analyzed by MALDI-TOF MS.
Measurement of CD spectrometry
Far-UV CD was recorded on a Jasco J-715 spectropolarimeter. Protein concentration was 0.2 mg´mL 21 in 20 mm sodium acetate buffer (pH 5.0). The spectra were recorded in a 0.1-cm cuvette in the far-UV region (190±250 nm).
Right-angle light-scattering experiments for analysis of protein aggregation
Right-angle light-scattering experiments were performed using a luminescence spectrometer (PerkinElmer LS50B) with both the emission and excitation wavelength selected at 400 nm. Under these conditions, the protein does not absorb or emit light and the signal measured is proportional to the intensity of scattered light [9] .
Proteolysis of mPrP(23±231)
a-Chymotrypsin and proteinase K in N-ethylmorpholine acetate (50 mm, pH 8.1) were used to digest mPrP(23±231). The ratio of substrate to enzyme was from 100 : 1 to 1 000 000 : 1 (10±0.001 mg´mL 21 ). Proteolysis was achieved at 37 8C for 1 h and stopped by addition of 2 vol. 4% trifluoroacetic acid, and the sample was then freeze-dried. Treated samples were analyzed by SDS/PAGE.
R E S U L T S Production of recombinant mPrP(23±231)
The murine prion mPrP(23±231) was expressed in Escherichia coli and harvested as inclusion bodies. It was then extracted and isolated in 8 m urea at neutral pH condition to give the reduced protein. After oxidative folding in 8 m urea under basic conditions [19] , the folded mPrP(23±231) was purified to homogeneity by cationexchange chromatography under nondenaturing conditions (Fig. 1) . The protein was dialyzed into the sodium acetate buffer (20 mm, pH 5.0) and concentrated using an Amicon YM10 membrane at 4 8C to a final concentration of 2.0 mg´mL
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. The protein was then stored at 220 8C. The relative molecular mass of purified mPrP(23±231) was determined by MALDI-TOF MS to be 23108.5 (calculated, 23106.5). N-Terminal sequencing identified the first ten residues to be SKKRPKPGGW, which is consistent with the known sequence. Correct folding of mPrP(23±231) (native, N) was confirmed by far-UV CD spectra, which measured a typical a helical far-UV CD spectra, with minima at 222 and 208 nm (see below). All data are consistent with the reported character of cellular mPrP [19] .
Oxidative folding of mPrP(23±231)
Folding of mPrP(23±231) requires the oxidation of a single disulfide bond. We have systematically investigated the effect of pH, redox agent and denaturant on the folding behavior of mPrP(23±231). When the reduced mPrP(23±231) was allowed to refold in buffer of different pH for up to 24 h using molecular oxygen as the oxidant, the optimal condition for the efficiency of refolding and the recovery of the native structure was found to be pH 4.0 ( Fig. 2A) . At pH values of 5.0 and 6.0, the efficiency of folding is comparable to that observed at pH 4.0, but the overall recovery is less satisfactory. At lower pH (3.0), folding of mPrP(23±231) hardly occurs. At higher pH (7.0±8.0), the yield of native structure is also extremely poor and there is a tendency for the reduced mPrP(23±231) to aggregate and precipitate out of the solution. Based on this initial study, we decided to focus on the folding experiments at pH 4.0, as well as pH 8.0, which is generally used for the study of oxidative folding of disulfidecontaining proteins [20] . This contrasting folding behavior of mPrP(23±231) at pH values 4.0 and 8.0 (Fig. 2) is reversed when the experiments were conducted in the presence of denaturant. In Tris/HCl buffer (pH 8.0) containing either urea (4 m) or GdmCl (2 m), quantitative recovery of the native form of mPrP(23±231) could be achieved within 8±24 h (Fig. 3) . At pH 4.0, however, the presence of denaturant has an unexpected negative effect on the folding of mPrP(23±231). The yield of the native species is extremely poor (less than 3%) (Fig. 3) . Instead, the majority of mPrP(23±231) sample was converted and trapped as three conformational isomers that are distinguished from both the native and reduced mPrP(23±231). These three isomers, designated`a',`b' and`c' (Fig. 3A) , all exhibit CD spectra of b sheet structure and all contain two free cysteines, as determined by MALDI -TOF MS after modification with vinylpyridine. Fig. 1 . SDS/PAGE (12%) of the mPrP(23±231) purification product. Lane 1, the harvested inclusion bodies; lane 2, the purified protein after oxidation and purification by cation-exchange chromatography. We further examined the effect of the redox agent oxidized glutathione (GSSG) on the folding property of mPrP(23±231). In the absence of denaturant, GSSG (0.25 mm) does not promote the folding of mPrP(23±231). This is true for folding experiments conducted both at pH 4.0 and 8.0 (Figs 4A and B) . In both cases, three fractions of intermediates (1, 2 and 3) were detected. Fractions 1, 2 and 3 are different from fractions a, b and c described in Fig. 3 . They are mixed disulfide reduced glutathione (GSH) conjugates of the reduced mPrP(23±231). Mass analysis revealed that fraction 1 contains mPrP(23± 231) conjugated with two molecules of GSH. Fractions 2 and 3 are each conjugated with one GSH. These data are consistent with those observed in the folding of hamster PrP27±30 in the presence of GSSG [15] . In the presence of denaturant (4 m urea), GSSG promotes the folding of mPrP(23±231), but only at pH 8.0 (Fig. 4D) . By comparing data presented in Figs 3B and 4D , it can be concluded that GSSG accelerates the folding of mPrP(23±231) by a factor of 15. However, GSSG has no detectable effect on the mPrP(23±231) folding performed at pH 4 and in the presence of 4 m urea. In both folding experiments (with and without GSSG), mPrP(23±231) was trapped as stable isomers`a',`b' and`c' with isomer`a' being the predominant species (compare the data given in Figs 3A and 4C). Reagents containing free thiols, such as GSH and b-mercaptoethanol, have no apparent effect on the folding process in any of the conditions employed for mPrP(23±231) folding (data not shown).
Properties of native, refolded and reduced mPrP(23±231)
Native and reduced mPrP(23±231) have different secondary structures. To date there is no bioassay available for prion protein. The simplest method available to check the folding is by CD spectroscopy. As shown in Fig. 5 , the CD spectrum of refolded mPrP(23±231) is almost superimposable on that of the native mPrP(23±231). Both have a helical structure. The reduced protein exhibits the typical spectrum of b sheet structure.
The reduced mPrP(23±231) is also distinguished from the native and refolded mPrP(23±231) by its marked resistance against proteolysis. Therefore, we compared their susceptibility to limited proteolysis using a wide range of proteases, including trypsin, a-chymotrypsin, pepsin, subtilisin, Glu-C, Asp-N and proteinase K. In all cases, the reduced mPrP(23±231) was shown to be more resistant than the native mPrP(23±231). Examples obtained from the analysis of proteinase K and a-chymotrypsin are shown in Fig. 6 . These results are consistent with those demonstrated for the reduced human prion [8] . The differences are most noticeable at dilute protease concentrations. For instance, when a-chymotrypsin digestion is compared at a concentration of 0.1 mg´mL
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, over 80% of the reduced mPrP(23±231) remains intact, while about 60% of the native mPrP(23±231) becomes fragmented within 1 h of digestion.
Finally, the reduced mPrP(23±231) exhibits a propensity for aggregation and precipitation in basic buffer (pH 8.0) that is not observed with the native mPrP(23±231). The right-angle scattering measurements indicate that as soon as the reduced mPrP(23±231) is brought to pH 8.0, it rapidly forms aggregates. Data presented in Fig. 7 show the relative intensity of light scattering following incubation of reduced mPrP(23±231) (0.1 mg´mL
) at pH 8.0. The relative intensity of scattered light reached a maximum once the sample was brought from pH 5.0 to pH 8.0 (the intensity at time zero was measured when the sample was in 20 mm sodium acetate buffer at pH 5.0). The maximal intensity is maintained for about 2 h and then gradually decreases, due to precipitation of aggregates. After incubation for 4 h, the precipitate could be observed by the naked eye. In contrast, no increase in the intensity of light scattering is observed with the incubation of native mPrP(23±231) under the same conditions. The precipitate of reduced mPrP(23±231) is soluble in GdmCl (6 m) or urea (8 m). Modification with 4-vinylpyridine, followed by mass analysis, indicates that the aggregated mPrP(23±231) retains two free cysteines.
D I S C U S S I O N
Oxidative folding of disulfide-containing protein represents a major technology for elucidating the folding pathways. For instance, a three-disulfide protein may adopt 74 possible nonnative disulfide isomers. The so-called disulfide folding pathway is characterized by the qualitative and quantitative presence of these isomers along the path that leads to the conversion of the fully reduced species to the fully oxidized native structure. This technology, pioneered by Creighton [ 21, 22] , has been meticulously applied to elucidate the folding mechanisms of several three-disulfide proteins [23±26], including the well-documented folding pathway of bovine pancreatic trypsin inhibitor [21, 22, 27, 28] . Diversities in folding mechanism, specifically regarding the extent of heterogeneity of folding intermediates, were observed among these proteins [29, 30] . However, a number of important factors, including pH, redox agent and denaturant, affect the oxidative folding of all these proteins in a similar and predictable manner [20, 27, 28] . Oxidative folding of mPrP(23±231), which contains one disulfide bond, involves a direct conversion of the reduced species to the oxidized native structure. Unlike proteins that contain multiple disulfide bonds, there are no additional disulfide isomers that may serve as folding intermediates of mPrP(23±231). Despite such simplicity, the folding behavior of mPrP(23±231) is anything but predictable. Numerous rules that are valid for documented disulfide proteins are simply not applicable to mPrP(23±231). Here we elaborate these unique properties of mPrP(23±231) folding.
Higher pH generally favors the disulfide formation and facilitates the oxidative folding [20] . For instance, increase in pH from 7.3 to 8.7 accelerates the rate of BPTI folding by approximately ten-fold [28] . For tick anticoagulant peptide, a decrease in pH by one unit from 8.4 to 7.4 lowers the rate of folding by a factor of six [31] . This is not the case for mPrP(23±231). The optimal pH for mPrP(23±231) folding is 4.0±5.0. At pH 8.0, folding and oxidation of mPrP(23±231) hardly occurs. This is true both in the absence or presence of redox agent.
The presence of GSSG typically provides redox potential that promotes disulfide formation and facilitates oxidative folding [20, 24, 32] . This phenomenon has been observed with all disulfide proteins investigated so far. In the case of hirudin folding, for example, the presence of GSSG (0.5 mm) increases the rate of disulfide formation by 40-fold [32] . Again, this is not the case for mPrP(23±231). The inclusion of GSSG does not promote mPrP(23±231) folding, either at pH 4.0 or at pH 8.0. One may recognize this by comparing chromatograms presented in Figs 2B and C to those given in Figs 4A and B. The only evidence that GSSG positively affects PrP(23±231) folding was observed at pH 8.0 with the concurrent presence of denaturant (Fig. 4D) .
Inclusion of denaturant usually impedes folding and reduces the recovery of the native structure [24, 26, 28] . This is because the presence of denaturant disrupts and nullifies noncovalent interactions that are required to stabilize the native protein [33] . Once more, this is not the case for mPrP(23±231). Indeed, the presence of denaturant facilitates rather than impedes the folding of mPrP(23±231). This positive effect of denaturant occurs when the folding of mPrP(23±231) is performed at pH 8.0, both in the absence (Figs 3B and C) and presence (Fig. 4D ) of GSSG.
All of these unusual properties of mPrP(23±231) can be adequately understood if one recognizes that the structure of the reduced mPrP(23±231) differs from the traditional forms of reduced and denatured proteins, which are typically disordered and unstructured [33, 34] . At alkaline and neutral pH values, reduced mPrP(23±231) must adopt a highly rigid conformation that inhibits the two cysteines from coming into contact to form the disulfide. This explains why the inclusion of GSSG has no effect on the mPrP(23±231) folding. The rigid and stable structure of reduced mPrP(23±231) may become denatured and partially unfolded at low pH or in the presence of denaturant. Denaturation of reduced mPrP(23±231) unfolds its rigid structure, lowers the energy barrier and facilitates the formation of disulfide bond. This accounts for the occurrence of mPrP(23±231) folding at pH 4±5. Most importantly, it satisfactorily explains the atypical positive effect of denaturant on the folding of mPrP(23±231). Indeed, the conformation of reduced mPrP(23±231) is probably more stable than that of native (oxidized) mPrP(23±231). This conclusion is sustained by the experimental data (Fig. 6 ) that demonstrate that reduced mPrP(23±231) is more resistant to enzyme digestion than the native mPrP(23±231). Reduced mPrP(23±231) also exhibits b sheet structure (Fig. 5) and is prone to form aggregates (Fig. 7) . These properties, which are structural hallmarks of the infectious scrapie prion [2, 3] , were similarly observed for the reduced form of human prion protein [8] .
Another important finding of this study is the identification of three novel conformational isomers of mPrP(23±231). These three isomers, designated`a',`b' and`c', were detected when folding of reduced mPrP(23± 231) was carried out at pH 4.0 in the presence of 4 m urea. The same intermediates were observed at urea concentration ranging from 2 m to 8 m. Surprisingly, they were largely absent when urea was replaced by GdmCl (2 m). These three isomers all contain two free cysteines and display characteristics of b sheet structure as signaled by their CD spectra (data not shown). They are distinguished from each other and also from the reduced mPrP(23±231) (starting material of folding) evidently by different sets of noncovalent interactions that stabilized their distinctive structures. The fact that they can be fractionated and identified by HPLC, following separation from urea, indicates that the prion protein molecule is capable of adopting various forms of stable conformational isomer segregated by energy barriers. This finding is a unique property of prion protein that has long been expected [8, 9, 16, 35, 36] and is part of the central dogma of prion disease [1±3].
A C K N O W L E D G E M E N T S
We would like to thank R. Glockshuber for the gift of the plasmid for mouse prion protein expression. The authors are also grateful to the support of the endowment from the Robert Welch foundation.
